Raffles Medical posts 63.8% drop in H2 profit to S$30.3 million; looks to China, Japan growth
RAFFLES Medical Group : BSL 0% posted a 63.8 per cent drop in net profit to S$30.3 million for the second half ended Dec 31, 2023, from S$83.7 million in the previous corresponding period.
The group attributed the weaker performance to the discontinuation of Covid-19-related activities in FY2023, it said on Monday (Feb 26).
The results translate to earnings per share (EPS) of 1.63 Singapore cents against EPS of 4.51 cents previously.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Malaysia Airports to be taken private by consortium led by Khazanah, EPF
Seatrium, CDL, Jardine C&C among stocks battered after MSCI index exclusion
Qatar to sign more long-term LNG contracts this year, QatarEnergy CEO says
LSEG investors offload shares worth £1.6 billion
JGB yields slide as US CPI data snags focus from BOJ policy
ABN Amro rides high rates with first-quarter net profit beat